This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Phillips, G. B. Articles by Jing, T.-Y. Search for Related Content PubMed PubMed Citation Articles by Phillips, G. B. Articles by Jing, T.-Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL TESTOSTERONE

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1383-1387.)
© 1996 American Heart Association, Inc.

Articles

The Association of Hyperestrogenemia With Coronary Thrombosis in Men

Gerald B. Phillips; Bruce H. Pinkernell; Tian-Yi Jing

the Department of Medicine, Columbia University College of Physicians and Surgeons, St. Luke's–Roosevelt Hospital Center, New York, NY.

Correspondence to Dr Gerald B. Phillips, Roosevelt Hospital, 1000 Tenth Ave, New York, NY 10019.

Both hyperestrogenemia and hypotestosteronemia have been reported in association with myocardial infarction (MI) in men. It was previously observed that the serum testosterone concentration correlated negatively with the degree of coronary artery disease (CAD) in men who had never had a known MI. The present study investigated the relationship of sex hormone levels to the thrombotic component of MI by comparing these levels in 18 men who had had an MI (ie, thrombosis) and 50 men with no history of MI (ie, no thrombosis) whose degree of CAD was in the same range. The mean degree of CAD, age, and body mass index in these two groups was not significantly different. The mean serum estradiol level in the men who had had an MI (38.5±8.8 pg/mL) was higher (P=.002) than the level in the men who had not had an MI (31.9±7.1 pg/mL). The mean levels of testosterone, free testosterone, sex hormone–binding globulin, insulin, dehydroepiandrosterone sulfate, cholesterol, HDL cholesterol, and systolic and diastolic blood pressure did not differ significantly. Estradiol was the only variable measured that showed a significant relationship to MI (P<.003 by multivariate logistic regression). These findings suggest that hyperestrogenemia may be related to the thrombosis of MI.

Key Words: estradiol • estrogen • testosterone • myocardial infarction • coronary thrombosis

This article has been cited by other articles:

				R. D. Abbott, L. J. Launer, B. L. Rodriguez, G. W. Ross, P.W.F. Wilson, K. H. Masaki, D. Strozyk, J. D. Curb, K. Yano, J. S. Popper, et al. Serum estradiol and risk of stroke in elderly men Neurology, February 20, 2007; 68(8): 563 - 568. [Abstract] [Full Text] [PDF]

				A. Tivesten, J. Hulthe, K. Wallenfeldt, J. Wikstrand, C. Ohlsson, and B. Fagerberg Circulating Estradiol Is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4433 - 4437. [Abstract] [Full Text] [PDF]

				K. H. Mikulec, L. Holloway, R. E. Krasnow, H. Javitz, G. E. Swan, T. Reed, R. Marcus, and D. Carmelli Relationship of Endogenous Sex Hormones to Coronary Heart Disease: A Twin Study J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1240 - 1245. [Abstract] [Full Text] [PDF]

				G. B. Phillips RE: "SHAVING, CORONARY HEART DISEASE, AND STROKE: THE CAERPHILLY STUDY" Am. J. Epidemiol., December 1, 2003; 158(11): 1123 - 1124. [Full Text] [PDF]

				M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF]

				A. W. van den Beld, M. L. Bots, J. A. M. L. L. Janssen, H. A. P. Pols, S. W. J. Lamberts, and D. E. Grobbee Endogenous Hormones and Carotid Atherosclerosis in Elderly Men Am. J. Epidemiol., January 1, 2003; 157(1): 25 - 31. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine and Lipid Responses to Chronic Androstenediol-Herbal Supplementation in 30 to 58 Year Old Men J. Am. Coll. Nutr., October 1, 2002; 20(5): 520 - 528. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4074 - 4080. [Abstract] [Full Text]

				P. H. McNulty, D. Jagasia, J. M. Whiting, and T. Caulin-Glaser Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1030 - H1034. [Abstract] [Full Text] [PDF]

				K. Sudhir and P. A. Komesaroff Cardiovascular Actions of Estrogens in Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3411 - 3415. [Full Text] [PDF]

				D. S. King, R. L. Sharp, M. D. Vukovich, G. A. Brown, T. A. Reifenrath, N. L. Uhl, and K. A. Parsons Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men: A Randomized Controlled Trial JAMA, June 2, 1999; 281(21): 2020 - 2028. [Abstract] [Full Text] [PDF]